Form 483

Rhode Island Blood Center, A Division of New York Blood Center, Inc. Form 483, 2012-06-21

FDA issued a Form 483 to Rhode Island Blood Center, A Division of New York Blood Center, Inc. on 2012-06-21 with 9 public-safe observations.

483· Form 483 issued9 observations

Rhode Island Blood Center, A Division of New York Blood Center, Inc. · Providence, United States · Issued June 21, 2012

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Jun 2012
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Lorayne A Mcguinness, Elizabeth B Griffin

21 Jun 2012
21 CFR 211.100(a)

Changes to Procedures Not Reviewed, Approved

Cited by Lorayne A Mcguinness, Elizabeth B Griffin

21 Jun 2012
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Lorayne A Mcguinness, Elizabeth B Griffin

21 Jun 2012
21 CFR 600.10(b)

Personnel capabilities

Cited by Lorayne A Mcguinness, Elizabeth B Griffin

21 Jun 2012
21 CFR 606.60(a)

Equipment observed, standardized, calibrated

Cited by Lorayne A Mcguinness, Elizabeth B Griffin

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 600.10(b)Cited across public-safe Form 483 observations1x
21 CFR 606.100(b)Cited across public-safe Form 483 observations1x
21 CFR 606.160(b)Cited across public-safe Form 483 observations1x
21 CFR 606.60(a)Cited across public-safe Form 483 observations1x
21 CFR 606.65Cited across public-safe Form 483 observations1x
21 CFR 610.41Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere